Study of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney Cancer

NCT01274273 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

118

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Renal Cell Carcinoma

Interventions

DRUG: Interleukin-2
DRUG: Interferon Alfa-2b
DRUG: Bevacizumab

Sponsor

University of Aarhus

Collaborators

[object Object]